Chemotherapy and Chemoprevention by Thiazolidinediones
Thiazolidinediones (TZDs) are synthetic ligands of Peroxisome-Proliferator-Activated Receptor gamma (PPARγ). Troglitazone, rosiglitazone, and pioglitazone have been approved for treatment of diabetes mellitus type II. All three compounds, together with the first TZD ciglitazone, also showed an antit...
Main Authors: | Eleonore Fröhlich, Richard Wahl |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/845340 |
Similar Items
-
Study of Chemotherapy and Chemoprevention in Nasopharyngeal Carcinoma
by: HSU, CHIH-HUNG, et al.
Published: (2002) -
Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases
by: Eleonore Fröhlich, et al.
Published: (2017-05-01) -
Physiological Role and Use of Thyroid Hormone Metabolites - Potential Utility in COVID-19 Patients
by: Eleonore Fröhlich, et al.
Published: (2021-04-01) -
The Role of Nutraceuticals in Chemoprevention and Chemotherapy and Their Clinical Outcomes
by: Sabita N. Saldanha, et al.
Published: (2012-01-01) -
Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
by: Shoko Horita, et al.
Published: (2015-01-01)